Back to LPCN

Rosalind Advisors, Inc. → LPCN

Rosalind Advisors, Inc. LPCN Position History

Lipocine Inc. • Healthcare

Quarters held
1
Latest value
$1.8M
Q1 2026
Peak value
$1.8M
First seen
Q1 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q1 2026$1.8M221.6K——

Other funds holding LPCN

Other Rosalind Advisors, Inc. positions

DCTH

DELCATH SYSTEMS, INC.

$52.7M
DCTH

DELCATH SYSTEMS, INC.

$41.6M
FENC

FENNEC PHARMACEUTICALS INC

$34.3M
VSTM

VERASTEM INC

$34.1M
FENC

FENNEC PHARMACEUTICALS INC

$34M
DCTH

DELCATH SYSTEMS, INC.

$33M
DCTH

DELCATH SYSTEMS, INC.

$30.6M
XERS

XERIS BIOPHARMA HOLDINGS INC

$24.7M